摘要
目的:研究血管活性肠肽(vasoactive intestinal peptide,VIP)在人膝骨关节炎滑膜中的表达特点,并探讨其与患者膝关节疼痛程度之间的相关性。方法:采集18例骨关节炎患者膝关节滑膜,根据术前视觉模拟疼痛评分(visual analogue scale,VAS)分为轻中度疼痛组(M组)和重度疼痛组(S组),7例外伤病人滑膜作为对照组(C组)。检测患者和正常人滑膜内VIP的含量和位置。结果:正常膝关节和骨关节炎膝关节滑膜均表达VIP,滑膜衬里层和衬里下层的表达无显著性差异(P>0.05)。轻中度疼痛组(M组)滑膜VIP表达高于对照组(C组)和重度疼痛组(S组)(P<0.05)。VIP与疼痛无线性相关。结论:VIP可能在人膝骨关节炎中参与轻度致痛作用,而在重度疼痛中不起主要作用。
Objective: To detect the vasoactive intestinal peptide (VIP) expression in ht, man knee osteoarth- ritis synovium and the relationship between VIP and knee osteoarthritic pain. Methods: Osteoarthritic knee synovium tissues from 18 patients were collected. According to visual analogue scale (VAS), the synovium tissues were divided into two groups: mild to moderate pain group (M group) and severe pain group (S group). Normal knee synoviurn tissues l^om 7 patients with trauma were collected as control (C group). The VIP expression and location were observed. Results: VIP was expressed in both normal and osteoarthritis knee joint synovium, and there are no difference in VIP expression between synovial lining and sublining layer (P 〉 0.05). The VIP expressed in mild to moderate pain group (M group) was higher than that in the control group (C group) and severe pain group (S group) (P 〈 0.05). VIP expression in synovial has no linear correlation with pain scores. Conclusion: VIP involves in mild to moderate pain in human knee osteoarthritis, but may not play a major role in the severe pain.
出处
《中国疼痛医学杂志》
CAS
CSCD
北大核心
2012年第7期413-417,共5页
Chinese Journal of Pain Medicine
基金
湖南省发展与改革委员会项目资助[2007]896
关键词
血管活性肠肽
骨关节炎
滑膜
疼痛
Vasoactive intestinal peptide
Osteoarthritis
Synovium
Pain